Amgen to Present at the 19th Annual Morgan Stanley Global Healthcare Conference

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will present at Morgan Stanley's 19th Annual Global Healthcare Conference on September 14, 2021, at 2:45 p.m. ET. CEO Robert A. Bradway will lead the presentation, which will be available for live streaming online, accessible to media, investors, and the public. The webcast can be found on Amgen's official website under the Investors section and will be archived for 90 days post-event. Amgen is known for its focus on discovering and developing innovative therapies aimed at unmet medical needs.

THOUSAND OAKS, Calif., Sept. 9, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Morgan Stanley's 19th Annual Global Healthcare Conference at 2:45 p.m. ET on Tuesday, Sept. 14, 2021. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. Live audio of the conference call will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given at certain investor and medical conferences, can be accessed on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631 (media)
Arvind Sood, 805-447-1060 (investors) 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-19th-annual-morgan-stanley-global-healthcare-conference-301373001.html

SOURCE Amgen

FAQ

When is Amgen's presentation at the Morgan Stanley Global Healthcare Conference?

Amgen's presentation is scheduled for September 14, 2021, at 2:45 p.m. ET.

Who will present at the Morgan Stanley Global Healthcare Conference for Amgen?

CEO Robert A. Bradway will present at the conference.

How can I access Amgen's conference presentation?

The presentation will be live-streamed and can be accessed on Amgen's official website under the Investors section.

Will the Amgen presentation be available later?

Yes, the webcast will be archived and available for replay for at least 90 days after the event.

What is Amgen's focus in the biotechnology sector?

Amgen focuses on discovering and developing innovative human therapeutics for serious illnesses and unmet medical needs.